SARATOGA, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today reported financial results and provided a business update for its third quarter ended September 30, 2026. Recent Highlights Reported third quarter 2026 revenue of $3.6 million, compared with $3.5 million in the third quarter 2025.CapsoCam Plus® used by more than 184,000 patients worldwide as of Septembe ...